Awardee OrganizationLSU PENNINGTON BIOMEDICAL RESEARCH CTR
Description
Abstract Text
Project Summary/Abstract
In the US, COVID-19 unveiled a disproportionate health burden in low income and underserved segments of
society. In Louisiana, some of the greatest health and economic consequences are evident in our Black
communities. Furthermore, despite the widespread availability of SARS-CoV-2 vaccines, approximately 30% of
the US population reports that they will not get vaccinated, and Black citizens and those with lower socio-
economic status are more likely to have vaccine hesitancy. Thus, there is an urgent need to address vaccine
hesitancy within the context of the COVID-19 pandemic and the current testing environment. The Louisiana
Clinical and Translational Science (LA CaTS) Center provides the essential infrastructure and key foundational
support for biomedical research in our region and is uniquely positioned to lead a community-engaged
research project to determine solutions to decrease vaccine hesitancy and improve testing rates in our most
underserved populations. Faith-based organizations (churches, mosques, temples, etc.) are trusted sources of
information, especially among Black communities, and may represent an opportunity to convey accurate,
unbiased health information regarding COVID-19 vaccinations and testing to the community. Many Black
churches have well-developed health ministries that integrate faith and health for their members and the
communities they serve. We will use a mixed-methods study design to determine the effectiveness of
training church health ministers to educate their congregations about the safety and efficacy of
COVID-19 vaccines for decreasing vaccine hesitancy and improving testing knowledge in underserved
Black communities. We will randomize 98 participants from five churches to an intervention group that will
receive counseling from their health ministers on the benefits of getting vaccinated and tested, or to a delayed
intervention control group. The effects of the intervention on the primary outcome, vaccine hesitancy measured
by a structured questionnaire, will be studied after three weeks. Following the three-week control period, the
delayed intervention control group will also receive the intervention. We will then conduct focus groups among
a sub-sample of participants to obtain more granular information on sources of vaccine hesitancy and for their
vaccine-related decisions. The achievement of the study's goals will significantly increase our understanding of
vaccine hesitancy within Black urban communities in Louisiana. Our results will inform the development of
targeted interventions to increase vaccine coverage in the large, underserved populations across the American
South.
Public Health Relevance Statement
Project Narrative
Despite the widespread availability of SARS-CoV-2 vaccines, approximately 30% of the US population reports
that they will not get vaccinated, and Black citizens and those with lower socio-economic status are more likely
to have vaccine hesitancy. The proposed project will determine the effectiveness of training church health
ministers to educate their congregations about the safety and efficacy of COVID-19 vaccines for decreasing
vaccine hesitancy and the importance of continued testing in underserved Black communities. The results will
significantly increase our understanding of vaccine hesitancy within urban, underserved Black communities in
the Southern United States.
No Sub Projects information available for 3U54GM104940-06S4
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 3U54GM104940-06S4
Patents
No Patents information available for 3U54GM104940-06S4
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 3U54GM104940-06S4
Clinical Studies
No Clinical Studies information available for 3U54GM104940-06S4
News and More
Related News Releases
No news release information available for 3U54GM104940-06S4
History
No Historical information available for 3U54GM104940-06S4
Similar Projects
No Similar Projects information available for 3U54GM104940-06S4